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A 62-year-old man, with a family history of prostate cancer, referred to our hospital because of elevated
prostate-specific antigen (PSA) (6.02 ng/ml). After prophylactic administration of antibiotics (cefotiam),
transrectal needle biopsy of the prostate was performed. He was admitted to the hospital due to high fever
the next evening. His blood pressure was below the shock level, and his renal function deteriorated
progressively. Suspecting septic shock, the patient was treated with Meropenem, γ-globulin, and dopamine,
which were not effective. Then, endotoxin adsorption therapy was employed and the condition of the
patient recovered soon after the initiation of the therapy. Extended spectrum β -lactamase-producing
Escherichia coli was found in his urine. Pathological diagnosis of the biopsy specimen was atypical glands.
(Hinyokika Kiyo 59 : 593-596, 2013)











患 者 : 62歳，男性
主 訴 : 頻尿
既往歴 : 高血圧・高脂血症
家族歴 : 父 前立腺癌
現病歴 : 2012年 4月に頻尿を主訴として近医を受診






経過 1 : 希望により経直腸前立腺針生検（ 8カ所）
を行った．後日明らかとなった病理結果は異型腺管の
みであった．感染予防として前日から cefotiam






体 温 : 38.4°C
血 圧 : 86/58 mmHg
脈 拍 : 111回/分
入院時身体所見 : 胸腹部理学所見に特記すべき所見
を認めなかった．
血液検査所見 : WBC 5,690/μ l，Neu 96.4％，Plt
11.5×104/μl，BUN 15 mg/dl，Cre 1.43 mg/dl，CRP
0.4 mg/dl，DIC score : 5点．




(MEPM) 1.5 g/day の投与を開始した．昇圧のため
ドーパミンの投与を開始したが，入院後 8時間の時点
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Fig. 1. Clinical course of the patient. The condition of the patient was dramatically improved after the introduction
of endotoxin adsorption therapy. Urine volume was measured every two hours. Abbreviations : DOA,









Table 1. Susceptibilities of antimicrobial agents
against the ESBL produced Escherichia
coli isolated from the urine of the patient




Cefpodoxime ＞ 4 R
Cefmetazole ＜ 4 S
Cefotiam ＞16 R
Flomoxef ＜ 8 S
Clauvulanic acid/Amoxicillin ＜ 8 S
Imipenem/Cilastatin ＜ 1 S
Gentamicin ＜ 1 S
Amikacin ＜ 4 S
Minocycline ＜ 1 S
Levofloxacin ＞ 4 R
Fosfomycin ＜ 4 S
Abbreviations : ESBL, extended spectrum beta-lactamase : R,





されず (5.0 pg/ml 未満，検出感度以下），血液培養は
陰性であったが，尿培養より ESBL 産生大腸菌が
103/ml 検出された．この ESBL 産生大腸菌の薬剤感


















(Table 2）．うち 2 例は死亡しており，致死的になる
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1 60 6 Yes Amikacin E. coli Unknown Unknown Yes Alive Kato, et al.4)
2 70 7 Yes Cefotiam E. coli Unknown Unknown No Dead Kumagai, et al.5)
3 73 4 Unknown Unknown Unknown Unknown Unknown Unknown Alive Maruyama, et al.6)
4 46 7 No Piperacilin E. coli R No Yes Dead Hasegawa, et al.7)
5 57 6 No Levofloxacin E. coli R No No Alive Endou, et al.8)
6 63 8 No Levofloxacin E. coli R No Yes Alive Hoshi, et al.9)
7 64 8 No Cefazolin E. coli R Unknown No Alive Hoshi, et al.9)
8 66 8 No Cefotiam E. coli R Unknown No Alive Oota, et al.10)
9 51 Unknown Unknown Unknown E. coli R Unknown Unknown Alive Ogawa, et al.11)
10 62 Unknown Unknown Unknown E. coli Unknown Unknown Unknown Alive Murata, et al.12)
11 64 Unknown Unknown Unknown E. coli Unknown Unknown Unknown Alive Murata, et al.12)
12 65 Unknown Unknown Unknown E. coli Unknown Unknown Unknown Alive Murata, et al.12)
13 51 10 No Prulifloxacin E. coli R Unknown Unknown Alive Imasato, et al.13)
14 59 12 No Cefazolin E. coli R Yes Yes Alive Hori, et al.14)
15 63 12 No Tosufloxacin E. coli R Yes No Alive Hiraga, et al.3)
16 64 6 No Levofloxacin E. coli R No Yes Alive Kato, et al.15)
17 62 8 No Cefotiam E. coli R Yes Yes Alive Current case
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